Title : Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.

Pub. Date : 2020 Jan

PMID : 31853327






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens
2 Notably, the results demonstrated that dexamethasone eradicated the promotion effects of TGF-beta1 on the AKT/epithelial-mesenchymal transition process and lenvatinib extinguished tumor cell metastasis by targeting VEGF. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens
3 In conclusion, dexamethasone inhibited AKT/ERK phosphorylation and lenvatinib antagonism bound VEGF leading to the limitation of migration and invasion of cancer cells in NSCLC. Dexamethasone AKT serine/threonine kinase 1 Homo sapiens